OCULIS HOLDING AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.9 USD | +0.42% |
|
0.00% | +5.97% |
| 10:00am | Oculis Holding AG Announces Board and Committee Appointments | CI |
| 08/05 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Oculis Holding AG
40d62ec2b115d0eaa995f7.1dTmkNr_1r1VsGEDrrl1K7iDI6mUdDm1Yk3VrD4jSuk.oOKx2e3HpdBg3Qtzl49AaeH6a8jiRU-DKjSa2VIQA6TkmZOlq4-s2TaDMA~ca2b422dbec127826c7f01c1f0acc150
Upcoming events on Oculis Holding AG
No events available
Past events on Oculis Holding AG
| 29/05/2024 07:00 pm | Annual General Meeting |
| 15/05/2024 11:50 pm | BofA Securities Health Care Conference |
| 09/05/2024 | Retina World Congress |
| 09/05/2024 01:40 am | Q1 2024 Earnings Release |
| 16/04/2024 | Van Lanschot Kempen Life Sciences Conference |
| 11/04/2024 05:30 pm | Needham Healthcare Conference |
| 07/04/2024 | American Society of Cataract and Refractive Surgery Meeting |
| 18/03/2024 04:00 pm | Q4 2023 Earnings Release |
| 13/03/2024 08:10 pm | Leerink Partners Global Biopharma Conference |
| 28/02/2024 07:30 pm | R&D Day |
| 08/02/2024 04:10 pm | BioCapital Europe Conference |
| 07/02/2024 08:00 pm | Stifel Biotech Executive Summit |
| 02/02/2024 04:00 am | Next Generation Ophthalmic Drug Delivery Summit |
| 28/11/2023 | Piper Sandler Healthcare Conference |
| 27/11/2023 07:30 pm | BTIG Ophthalmology Day |
| 15/11/2023 08:15 pm | Stifel Healthcare Conference |
| 06/10/2023 03:45 pm | Euretina Conference |
| 14/09/2023 05:40 pm | Pareto Securities HC Conference |
| 11/09/2023 06:00 pm | H.C. Wainwright Global Investment Conference |
| 07/09/2023 | Ophthalmology Futures European Forum |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,88 0,78 12.87% | 0,93 |
|
EBITDA Million CHF | Released Forecast Spread | 0,00 | -80,4 -60,3 -33.47% | -55,1 |
|
EBIT Million CHF | Released Forecast Spread | 0,00 | -80,7 -75,0 -7.67% | -67,6 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 0,00 | -88,7 -87,3 -1.57% | -68,3 |
|
Net income Million CHF | Released Forecast Spread | -38,7 | -88,8 -83,8 -5.92% | -66,7 |
|
EPS CHF | Released Forecast Spread | -12,9 | -2,97 -2,92 -1.59% | -1,72 |
| Announcement Date | 28/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,19 | 0,25 0,19 31.75% | 0,22 0,17 30.23% | 0,19 0,21 -11.49% | 0,22 0,26 -13.88% | 0,27 | 0,26 | 0,22 | ||
|
EBITDA Million CHF | Released Forecast Spread | -9,39 | -10,4 | -12,9 -9,18 -40.33% | -12,1 -12,7 4.31% | ||||||
|
EBIT Million CHF | Released Forecast Spread | -9,57 | -10,7 -10,2 -5.77% | -13,0 -10,7 -21.57% | -12,2 -13,4 9.26% | -15,3 -13,8 -10.77% | -16,3 | -17,1 | -18,9 | ||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -11,1 | -12,8 -11,9 -7.48% | -17,5 -11,7 -49.93% | -12,5 -13,7 8.67% | -16,1 -13,1 -23.02% | -16,4 | -17,3 | -18,3 | ||
|
Net income Million CHF | Released Forecast Spread | -9,78 | -12,9 -10,1 -26.87% | -17,4 -11,3 -53.72% | -12,5 -14,6 14.18% | -16,1 -13,6 -18.44% | -16,0 | -16,7 | -18,0 | ||
|
EPS CHF | Released Forecast Spread | -0,30 | -0,38 -0,29 -28.91% | -2,53 -0,51 -396.08% | -0,48 -0,33 -46.75% | -0,34 -0,40 15.11% | -0,48 | -0,44 -0,37 -18.28% | -0,42 | -0,44 | -0,46 |
| Announcement Date | - | 29/08/23 | 29/08/23 | 15/11/23 | 18/03/24 | - | 08/05/24 | - | - | - |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Oculis Holding AG
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | NUVATION BIO INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OCS Stock
- Calendar Oculis Holding AG
